Mineralys Therapeutics
MLYS
MLYS
68 hedge funds and large institutions have $429M invested in Mineralys Therapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 10 closing their positions.
Holders
68
Holders Change
+1
Holders Change %
+1.49%
% of All Funds
1.07%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
31
Reduced
9
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$12.5M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$15.8M |
| 3 |
3
BlackRock
New York
|
$15.1M |
| 4 |
DM
4
Deerfield Management
New York
|
$14.3M |
| 5 |
5
Bank of Montreal
Toronto,
Ontario, Canada
|
$1.51M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Wellington Management Group
Boston,
Massachusetts
| – | – | -24,224 | Closed |
|
|
CSS
77
Cubist Systematic Strategies
Stamford,
Connecticut
| – | – | -10,227 | Closed |
|
78
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | – | -13 | Closed |
|
|
CFGS
79
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|